Registration

ANGELA STEWART for EISAI, INC

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative

LobbyistCovered position, as disclosed
ANGELA STEWART New Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner

Bills named: S. 810 (114th), H.R. 2 (114th), S. 481 (114th), H.R. 639 (114th)

Budget/Appropriations BUD

Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative

LobbyistCovered position, as disclosed
ANGELA STEWART New Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner

Bills named: H.R. 2 (114th), S. 481 (114th), S. 810 (114th), H.R. 639 (114th)

Pharmacy PHA

Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative

LobbyistCovered position, as disclosed
ANGELA STEWART New Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner

Bills named: H.R. 2 (114th), H.R. 639 (114th), S. 481 (114th), S. 810 (114th)

Health Issues HCR

Act (P.L. 113-54)Regulatory and legislative health care issues, including the 340B program; DEA scheduling of controlled substances H.R. 639/S. 481-Improving Regulatory Transparency for New Medical Therapies Act;Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of FDA-approved obesity drugs.H.R. 2- Medicare Access and CHIP Reauthorization Act of 2015 S. 810 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015; Potential pharmaceutical reimbursement cuts (offsets); Innovation Cures Initiative

LobbyistCovered position, as disclosed
ANGELA STEWART New Legislative Counsel, Legislative Assistant, Legislative Correspondent, and Staff Assistant for Senator John Warner

Bills named: S. 810 (114th), S. 481 (114th), H.R. 2 (114th), H.R. 639 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.